Bio Competitors
| BIO Stock | USD 256.56 35.86 12.26% |
Bio Rad vs Masimo Correlation
Very weak diversification
The correlation between Bio Rad Laboratories and MASI is 0.43 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bio Rad Laboratories and MASI in the same portfolio, assuming nothing else is changed.
Moving together with Bio Stock
As of the 14th of February 2026, Return On Equity is likely to grow to 0.11, while Return On Tangible Assets are likely to drop 0.06. At this time, Bio Rad's Other Assets are very stable compared to the past year. As of the 14th of February 2026, Net Tangible Assets is likely to grow to about 11.1 B, while Deferred Long Term Asset Charges is likely to drop about 15.6 M.Bio Rad Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bio Rad and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Bio and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bio Rad Laboratories does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Bio Stock performing well and Bio Rad Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bio Rad's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| GMED | 1.26 | (0.02) | (0.02) | 0.04 | 1.26 | 3.63 | 7.49 | |||
| ALGN | 1.74 | 0.38 | 0.21 | 0.29 | 1.60 | 4.70 | 15.79 | |||
| ATR | 1.12 | 0.27 | 0.19 | 0.36 | 1.11 | 2.93 | 8.45 | |||
| HSIC | 1.20 | 0.05 | 0.03 | 0.12 | 1.45 | 2.43 | 7.52 | |||
| GRFS | 1.37 | 0.09 | 0.04 | 0.19 | 1.66 | 3.23 | 8.28 | |||
| HQY | 1.64 | (0.49) | 0.00 | (0.48) | 0.00 | 2.51 | 12.83 | |||
| CRL | 1.82 | (0.09) | (0.02) | 0.01 | 2.72 | 3.93 | 14.56 | |||
| PEN | 1.37 | 0.31 | 0.19 | 0.50 | 1.17 | 3.37 | 16.34 | |||
| DVA | 1.83 | 0.36 | 0.17 | 3.22 | 1.54 | 4.25 | 26.79 | |||
| MASI | 1.59 | (0.19) | 0.00 | (0.21) | 0.00 | 3.02 | 10.00 |
Cross Equities Net Income Analysis
Compare Bio Rad Laboratories and related stocks such as Globus Medical, Align Technology, and AptarGroup Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GMED | 48.7 M | 60.8 M | 73.8 M | 68.6 M | 92.5 M | 112.8 M | 104.3 M | 107.3 M | 156.5 M | 155.2 M | 102.3 M | 149.2 M | 190.2 M | 122.9 M | 103 M | 118.4 M | 117.1 M |
| ALGN | (15.4 M) | 66.7 M | 58.7 M | 64.3 M | 145.8 M | 144 M | 189.7 M | 231.4 M | 400.2 M | 442.8 M | 1.8 B | 772 M | 361.6 M | 445.1 M | 421.4 M | 410.4 M | 234 M |
| ATR | 19.5 M | 183.7 M | 162.6 M | 172 M | 191.7 M | 199.3 M | 205.6 M | 220 M | 194.7 M | 242.2 M | 214 M | 244.1 M | 239.3 M | 284.5 M | 374.5 M | 392.8 M | 412.4 M |
| HSIC | (10.9 M) | 367.7 M | 388.1 M | 444.1 M | 466.1 M | 479.1 M | 506.8 M | 406.3 M | 535.9 M | 508 M | 402.2 M | 623.9 M | 538 M | 416 M | 390 M | 448.5 M | 301.7 M |
| GRFS | 25.6 M | 50.3 M | 256.7 M | 345.6 M | 470.3 M | 532.1 M | 545.5 M | 662.7 M | 596.6 M | 625.1 M | 618.5 M | 188.7 M | 185 M | 42.3 M | 156.9 M | 180.5 M | 320.1 M |
| HQY | 11.2 M | 11.2 M | 11.2 M | 1.2 M | 10.2 M | 16.6 M | 26.4 M | 47.4 M | 73.9 M | 39.7 M | 8.8 M | (44.3 M) | (26.1 M) | 55.7 M | 96.7 M | 111.2 M | 116.8 M |
| PEN | 2 M | 2 M | 2 M | 4.1 M | 2.2 M | 2.4 M | 14.8 M | 4.7 M | 6.6 M | 48.5 M | (19.3 M) | 2.6 M | (2 M) | 91 M | 14 M | 16.1 M | 14.5 M |
| DVA | 4.9 M | 478 M | 536 M | 633.4 M | 723.1 M | 269.7 M | 879.9 M | 663.6 M | 159.4 M | 811 M | 773.6 M | 978.5 M | 560.4 M | 691.5 M | 936.3 M | 746.8 M | 432.3 M |
| MASI | (6.5 M) | 63.7 M | 62.3 M | 58.4 M | 72.5 M | 83.3 M | 300.7 M | 131.6 M | 193.5 M | 196.2 M | 240.3 M | 229.6 M | 143.5 M | 81.5 M | (304.9 M) | (350.6 M) | (333.1 M) |
Bio Rad Laboratories and related stocks such as Globus Medical, Align Technology, and AptarGroup Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Bio Rad Laboratories financial statement analysis. It represents the amount of money remaining after all of Bio Rad Laboratories operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Bio Rad Competitive Analysis
The better you understand Bio Rad competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bio Rad's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bio Rad's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Bio Rad Competition Performance Charts
Five steps to successful analysis of Bio Rad Competition
Bio Rad's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Bio Rad Laboratories in relation to its competition. Bio Rad's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Bio Rad in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Bio Rad's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Bio Rad Laboratories, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Bio Rad position
In addition to having Bio Rad in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Munis Funds Thematic Idea Now
Munis Funds
Funds or Etfs that invest in fixed income securities issued by states, cities, and towns as well as other public entities. The Munis Funds theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Munis Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Bio Rad Correlation with its peers. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Will Life Sciences Tools & Services sector continue expanding? Could Bio diversify its offerings? Factors like these will boost the valuation of Bio Rad. Projected growth potential of Bio fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bio Rad data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.83) | Earnings Share 27.86 | Revenue Per Share | Quarterly Revenue Growth 0.039 | Return On Assets |
Bio Rad Laboratories's market price often diverges from its book value, the accounting figure shown on Bio's balance sheet. Smart investors calculate Bio Rad's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Bio Rad's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Bio Rad's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bio Rad should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.